Enliven Therapeutics
ELVN
#5603
Rank
$0.87 B
Marketcap
$17.91
Share price
0.22%
Change (1 day)
-2.13%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2024 (TTM): -$0.11 Billion USD

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$83.53 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 -$0.11 Billion25.17%
2023 -$83.53 Million115.33%
2022 -$38.8 Million